Novo Nordisk (NVO) Stock Drops as Legal War Erupts Over $49 Wegovy Knockoff

TLDR Novo Nordisk shares fell 7% Thursday when Hims & Hers introduced a $49 compounded Wegovy pill, compared to Novo’s $149 branded version The Danish pharmaceutical company plans legal action, labeling the product “illegal mass compounding” that threatens patient safety Eli Lilly stock also declined 7% as investors worried about increased market competition for weight [...]

The post Novo Nordisk (NVO) Stock Drops as Legal War Erupts Over $49 Wegovy Knockoff appeared first on Blockonomi.